RXST RxSight Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: RXST

Price (delayed)

$5.085

Market cap

$210.5M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.13

Enterprise value

$203M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 26
Highlights
RxSight's debt has decreased by 10% YoY
RxSight's gross margin has increased by 7% YoY
RXST's net income has dropped by 76% year-on-year and by 20% since the previous quarter
The EPS has dropped by 69% year-on-year and by 19% since the previous quarter
Sector: Healthcare
Industry: Medical Devices

Key stats

What are the main financial stats of RXST

RXST stock price

How has the RxSight stock price performed over time
Intraday
6.16%
1 week
-9.03%
1 month
-31.1%
1 year
-66.68%
YTD
-51.2%
QTD
-17.45%

Financial performance

How have RxSight's revenue and profit performed over time
Revenue
$127.48M
Gross profit
$98.18M
Operating income
-$55.35M
Net income
-$46.64M
Gross margin
77%
Net margin
-36.6%
RxSight's net margin has plunged by 104% YoY and by 26% from the previous quarter
RXST's net income has dropped by 76% year-on-year and by 20% since the previous quarter
The company's operating margin has shrunk by 74% YoY and by 21% QoQ
The operating income has plunged by 50% YoY and by 15% from the previous quarter

Price vs fundamentals

How does RXST's price correlate with its fundamentals

Growth

What is RxSight's growth rate over time

Valuation

What is RxSight stock price valuation
P/E
N/A
P/B
0.79
P/S
1.65
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.59
The EPS has dropped by 69% year-on-year and by 19% since the previous quarter
RXST's P/B is 84% below its 5-year quarterly average of 4.5 and 47% below its last 4 quarters average of 1.4
RXST's equity is down by 4.3% year-on-year and by 3% since the previous quarter
RXST's P/S is 85% below its 5-year quarterly average of 10.1 and 45% below its last 4 quarters average of 2.8
RXST's revenue is down by 14% year-on-year and by 5% since the previous quarter

Efficiency

How efficient is RxSight business performance
The return on sales has dropped by 105% year-on-year and by 26% since the previous quarter
RxSight's return on invested capital has shrunk by 83% YoY and by 21% QoQ
RXST's ROE has shrunk by 79% YoY and by 21% QoQ
The ROA has plunged by 78% YoY and by 21% from the previous quarter

Dividends

What is RXST's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for RXST.

Financial health

How did RxSight financials performed over time
RxSight's quick ratio has decreased by 23% YoY and by 8% from the previous quarter
The company's current ratio fell by 20% YoY and by 7% QoQ
RxSight's debt is 96% less than its equity
RxSight's debt has decreased by 10% YoY
RXST's equity is down by 4.3% year-on-year and by 3% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.